Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Possible DNA glycosylase | 0.0183 | 0.4879 | 1 |
Giardia lamblia | Isoleucyl-tRNA synthetase | 0.0052 | 0.0601 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.034 | 1 | 1 |
Mycobacterium tuberculosis | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA glycosylase) | 0.0183 | 0.4879 | 1 |
Leishmania major | isoleucyl-tRNA synthetase, putative | 0.0052 | 0.0601 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.034 | 1 | 1 |
Toxoplasma gondii | isoleucyl-tRNA synthetase family protein | 0.0052 | 0.0601 | 0.5 |
Loa Loa (eye worm) | isoleucyl-tRNA synthetase | 0.0052 | 0.0601 | 0.037 |
Trichomonas vaginalis | isoleucyl tRNA synthetase, putative | 0.0052 | 0.0601 | 0.5 |
Plasmodium vivax | isoleucine--tRNA ligase, putative | 0.0052 | 0.0601 | 0.5 |
Plasmodium falciparum | isoleucine--tRNA ligase, putative | 0.0201 | 0.5481 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0601 | 0.037 |
Echinococcus multilocularis | isoleucyl tRNA synthetase, cytoplasmic | 0.0052 | 0.0601 | 0.037 |
Onchocerca volvulus | 0.0041 | 0.024 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 1 | 1 |
Chlamydia trachomatis | isoleucine--tRNA ligase | 0.0052 | 0.0601 | 0.5 |
Treponema pallidum | isoleucyl-tRNA synthetase | 0.0052 | 0.0601 | 0.5 |
Mycobacterium leprae | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA GLYCOSYLASE) | 0.0183 | 0.4879 | 1 |
Trypanosoma cruzi | isoleucyl-tRNA synthetase, putative | 0.0052 | 0.0601 | 0.5 |
Brugia malayi | isoleucyl-tRNA synthetase family protein | 0.0052 | 0.0601 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.034 | 1 | 1 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0183 | 0.4879 | 1 |
Brugia malayi | isoleucyl-tRNA synthetase | 0.0052 | 0.0601 | 0.5 |
Entamoeba histolytica | isoleucyl-tRNA synthetase, putative | 0.0052 | 0.0601 | 0.5 |
Trypanosoma brucei | isoleucyl-tRNA synthetase, putative | 0.0052 | 0.0601 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | formamidopyrimidine-DNA glycosylase | 0.0183 | 0.4879 | 1 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0183 | 0.4879 | 1 |
Echinococcus granulosus | isoleucyl tRNA synthetase, cytoplasmic | 0.0052 | 0.0601 | 0.037 |
Echinococcus multilocularis | sodium:chloride dependent neurotransmitter | 0.034 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cures (functional) | = 1 | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 13.3 mg/kg expressed as mean surviaval time (MST) or cures | ChEMBL. | 7381860 |
Cures (functional) | = 5 | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 26.5 mg/kg expressed as mean surviaval time (MST) or cures | ChEMBL. | 7381860 |
Delta MST (functional) | T 0 day | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 424 mg/kg expressed as mean surviaval time (MST) or cures T - toxic death | ChEMBL. | 7381860 |
Delta MST (functional) | T 0 day | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 106 mg/kg expressed as mean surviaval time (MST) or cures T - toxic death | ChEMBL. | 7381860 |
Delta MST (functional) | = 1.3 day | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 6.6 mg/kg expressed as mean surviaval time (MST) or cures | ChEMBL. | 7381860 |
Delta MST (functional) | = 1.3 day | Tested for antitrypanosomal activity against trypanosoma rhodesiense in mice at dose of 6.6 mg/kg expressed as mean surviaval time (MST) or cures | ChEMBL. | 7381860 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.